WHO ICTRP trial
A Phase 1 Prospective, Open-label, First-in-human Study to Evaluate the Safety…
CTIS2023-508126-95-00 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2023-508126-95-00 |
|---|---|
| Public title | A Phase 1 Prospective, Open-label, First-in-human Study to Evaluate the Safety, Tolerability and Biodistribution of [177Lu]Lu-AKIR001 and its Anti-tumour Effect in Adult Patients with CD44v6 Expressing Solid Tumours |
| Scientific title | - AKIR001 |
| Primary sponsor | Karolinska University Hospital |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): Yes Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Sweden |
| Conditions | The target population of the trial consists of patients with locally advanced irresectable or metastatic solid malignancies, such as advanced thyroid cancer, squamous cell carcinoma originating from head and neck region, vulvar or cervix… |
| Registration date | Jun 25, 2024 |
| Target size | 30 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: